Heart attack cell therapy under Long-Term safety watch
NCT ID NCT07400458
First seen Feb 11, 2026 · Last updated May 19, 2026 · Updated 12 times
Summary
This study follows 100 people who had a heart attack and received the cell therapy Hearticellgram-AMI. Researchers are monitoring for serious side effects such as death, new cancers, or immune reactions over the long term. The goal is to ensure the treatment remains safe after it was approved.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDIAL INFARCTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
KIMHYUNSOO Clinic
RECRUITINGSeoul, Gangnam, 06017, South Korea
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.